Imdevimab - Research Grade Biosimilar

• NCBI Gene ID:

  43740568

• Swiss Prot:

  P0DTC2

• Accession Number:

  P0DTC2

• Immunogen:

  Homo sapiens / SARS-CoV-2 Spike RBD

• Clonality:

  Recombinant Monoclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies, Biosimilars

• Source:

  CHO cells

• Field of Research:

  Other

• Purification:

  >95%

• Concentration:

  Batch dependent

• Purity:

  >95%

• Buffer:

  PBS buffer pH 7.5

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.

• Fragment:

  IgG1, Lambda

• Symbol:

  S

• NCBI Official Name:

  Surface glycoprotein

• NCBI Organism:

  Severe acute respiratory syndrome coronavirus 2

• Other Product Names:

  IMDEVIMAB, IMDEVIMAB [INN], IMDEVIMAB [USAN], IMDEVIMAB [WHO-DD], IMMUNOGLOBULIN G1, ANTI- (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10987 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10987 .LAMBDA.-CHAIN, DIMER REGN10987, REGN-10987, , spike glycoprotein

• CAS Number:

  2415933-40-1